Dr. Andreas Mueller

Dr. Andreas Mueller, PhD

Head of Quality & Regulatory Affairs

Peptide GMP Manufacturing & FDA Compliance · 18+ years experience

Dr. Andreas Mueller brings 18 years of experience in peptide GMP manufacturing and global regulatory compliance. Based in Switzerland, he has guided 6 peptide-based drugs through FDA and EMA approval, including the first generic GLP-1 receptor agonist in Europe. He is an expert in ICH guidelines, quality-by-design (QbD) principles, and analytical method validation for complex peptide products. Andreas serves as a GMP inspector for Swissmedic and lectures at ETH Zurich.

Certifications: PhD Analytical Chemistry (ETH Zurich)RAC (Regulatory Affairs Certification)Six Sigma Black Belt
Key Projects:
  • Regulatory Lead — First Generic GLP-1 RA in Europe (2023)
  • GMP Inspector — Swissmedic (2018-present)
  • Lecturer — Pharmaceutical Quality Systems (ETH Zurich)

Articles by Dr. Andreas Mueller (3)

The Ultimate oneskin's peptide skin longevity age reversal moisturizer Checklist: 10 Things You Need to Verify — evidence-based analysis and expert insights from PeptaPulse.

2026-07-14

Step-by-Step: How precise peptides Can Transform Your Body Composition — evidence-based analysis and expert insights from PeptaPulse.

2026-07-14

How to Incorporate peptides for muscle growth and weight loss into Your Daily Wellness Routine — evidence-based analysis and expert insights from PeptaPulse.

2026-07-14

Business License

PeptaPulse is a research and educational platform. Business registration details available upon request at legal@peptapulse.com.